FI901371A0 - Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi

Info

Publication number
FI901371A0
FI901371A0 FI901371A FI901371A FI901371A0 FI 901371 A0 FI901371 A0 FI 901371A0 FI 901371 A FI901371 A FI 901371A FI 901371 A FI901371 A FI 901371A FI 901371 A0 FI901371 A0 FI 901371A0
Authority
FI
Finland
Prior art keywords
dihydrobenzothiopyranylamines
preparation
therapeutically useful
und
dieser verbindungen
Prior art date
Application number
FI901371A
Other languages
English (en)
Swedish (sv)
Other versions
FI94863B (fi
FI94863C (fi
Inventor
Alan J Hutchison
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI901371A0 publication Critical patent/FI901371A0/fi
Publication of FI94863B publication Critical patent/FI94863B/fi
Application granted granted Critical
Publication of FI94863C publication Critical patent/FI94863C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Tea And Coffee (AREA)
  • Indole Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI901371A 1989-03-22 1990-03-19 Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi FI94863C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32694989A 1989-03-22 1989-03-22
US32694989 1989-03-22

Publications (3)

Publication Number Publication Date
FI901371A0 true FI901371A0 (fi) 1990-03-19
FI94863B FI94863B (fi) 1995-07-31
FI94863C FI94863C (fi) 1995-11-10

Family

ID=23274473

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901371A FI94863C (fi) 1989-03-22 1990-03-19 Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi

Country Status (22)

Country Link
US (1) US5071858A (fi)
EP (1) EP0389425B1 (fi)
JP (1) JPH06102657B2 (fi)
KR (1) KR900014357A (fi)
AT (1) ATE121740T1 (fi)
AU (1) AU632318B2 (fi)
CA (1) CA2012569A1 (fi)
DD (1) DD292913A5 (fi)
DE (1) DE69018864D1 (fi)
DK (1) DK0389425T3 (fi)
ES (1) ES2071074T3 (fi)
FI (1) FI94863C (fi)
GR (1) GR3015938T3 (fi)
HU (1) HU206205B (fi)
IE (1) IE67871B1 (fi)
IL (2) IL93814A0 (fi)
MX (1) MX19953A (fi)
NO (1) NO174669C (fi)
NZ (1) NZ233002A (fi)
PT (1) PT93515B (fi)
TW (1) TW204347B (fi)
ZA (1) ZA902168B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8400891A (en) * 1990-08-13 1992-03-17 G.D. Searle & Co. Use of heterocyclic amino-alcohol compounds for treatment of cns diseases
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5428307A (en) * 1993-10-20 1995-06-27 Silicon Systems, Inc. Closed-loop peak detector topology
JPH0967367A (ja) * 1995-06-23 1997-03-11 Suntory Ltd チオピラン誘導体
FR2739855B1 (fr) * 1995-10-13 1997-11-14 Adir Nouvelles amines heterocycliques tertiaires, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20050148018A1 (en) * 1999-10-07 2005-07-07 David Weiner Methods of identifying inverse agonists of the serotonin 2A receptor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2077733B1 (fi) * 1970-02-10 1973-03-16 Roussel Uclaf
GB1407552A (en) * 1973-04-02 1975-09-24 Science Union & Cie Disubstituted piperazines processes for their preparation and pharmaceutical compositions containing them
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
US4468404A (en) * 1980-12-12 1984-08-28 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(triazolymethyl)benzo(b)thiophenes
FI79535C (fi) * 1982-05-06 1990-01-10 Erba Farmitalia Foerfarande foer framstaellning av dihydrobensopyrans och dihydrobensotiopyrans substituerade iminoderivat.
GB8515389D0 (en) * 1985-06-18 1985-07-17 Ici Plc Heterocyclic compounds
DE3771280D1 (de) * 1986-06-26 1991-08-14 Ciba Geigy Ag Hydrierte 1-benzooxacycloalkyl-pyridincarbonsaeureverbindungen.
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
GB8704572D0 (en) * 1987-02-26 1987-04-01 Lundbeck & Co As H Organic compounds
DE68908392T2 (de) * 1988-01-15 1994-02-10 Abbott Lab Aminomethyl-chroman- und -thiochroman-verbindungen.
ATE149480T1 (de) * 1990-08-15 1997-03-15 Lilly Co Eli Ring-substituierte 2-amino-1,2,3,4-tetra- hydronaphthaline, 3-aminochromane und 3- aminothiochromane

Also Published As

Publication number Publication date
NO174669C (no) 1994-06-15
IL93814A0 (en) 1990-12-23
KR900014357A (ko) 1990-10-23
DE69018864D1 (de) 1995-06-01
NO174669B (no) 1994-03-07
NZ233002A (en) 1992-07-28
IE901036L (en) 1990-09-22
ES2071074T3 (es) 1995-06-16
GR3015938T3 (en) 1995-07-31
DD292913A5 (de) 1991-08-14
JPH037280A (ja) 1991-01-14
NO901303L (no) 1990-09-24
FI94863B (fi) 1995-07-31
MX19953A (es) 1994-01-31
US5071858A (en) 1991-12-10
AU5208690A (en) 1990-11-08
AU632318B2 (en) 1992-12-24
TW204347B (fi) 1993-04-21
ATE121740T1 (de) 1995-05-15
PT93515A (pt) 1990-11-07
HU206205B (en) 1992-09-28
HU901636D0 (en) 1990-11-28
IE67871B1 (en) 1996-05-01
PT93515B (pt) 1996-08-30
IL93814A (en) 1995-07-31
EP0389425A1 (de) 1990-09-26
EP0389425B1 (de) 1995-04-26
HUT53632A (en) 1990-11-28
CA2012569A1 (en) 1990-09-22
NO901303D0 (no) 1990-03-21
DK0389425T3 (da) 1995-05-22
FI94863C (fi) 1995-11-10
JPH06102657B2 (ja) 1994-12-14
ZA902168B (en) 1990-11-28

Similar Documents

Publication Publication Date Title
DE3887625D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
DE59100830D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5,-trimethyl-cyclohexylamin.
ATE7697T1 (de) Substituierte pyrazinyl-1,2,4-oxadiazol-5-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DK140996A (da) Fremgangsmåde til fremstilling af 2,3,4,5-tetraflour-6-alkyl-benzoesyreforbindelser
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
ATE1238T1 (de) Neue 1,4-dihydropyridinverbindungen, verfahren zu ihrer herstellung, die genannten verbindungen enthaltende arzneimittel und verfahren zur herstellung dieser arzneimittel.
DE69008820D1 (de) Verfahren zur Behandlung von Polymerisaten.
NO902800D0 (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
DE59302501D1 (de) Substituierte Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
DE69011951D1 (de) Verfahren zur Behandlung und Herstellung von Material.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
FI901371A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi
LU79376A1 (de) 1,2,3-thiadiazol-3-in-5-yliden-harnstoffe,verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel mit wachstumsregulatorischer wirkung
PT69999A (de) 1,2,3-triazolcarbonsaureamide verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
DE59003390D1 (de) Verfahren zur Herstellung von Butandiol-1,4 und Tetrahydrofuran.
PT70560A (de) 1,3,4-thiadiazol-2-carbonsaure-derivate verfahren zur herstellung dieser verbindungen sowie diese enthaltende fungizide und nematizide mittel
ATE113598T1 (de) Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
PT76582B (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
ATE69809T1 (de) Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
ATE57912T1 (de) Verfahren zur herstellung von anilinofumarat und 2,3-chinolindicarbonsaeure.
DE59203960D1 (de) Verfahren zur Herstellung von reinem 3,3',4,4'-Tetraaminobiphenyl.

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed

Owner name: NOVARTIS AG